{
  "figure_1": "a-c, Skin tumor outcomes for DMBA-TPA-treated\nMmuPV1-colonized wild-type C57BL/6J mice (MmuPV1/DMBA-TPA, n =\n12), DMBA-TPA-treated sham-infected (Sham/DMBA-TPA, n = 10) and\nMmuPV1-colonized mice (MmuPV1/-, n = 10) determined by\n(a) tumor latency (Log-rank test), (b) tumor\ncounts per mouse over time, and (c) tumor burden at the completion\nof the carcinogenesis protocol (*p < 0.05, two-tailed\nMann-Whitney U test). d, The percentage of\nwild-type FVB mice with wart development on their back skin at five weeks and a\nsubgroup with persistent warts at ten weeks post MmuPV1 infection.\ne, T cells from skin-draining lymph nodes of MmuPV1-colonized\nimmune mice (test T cells) transferred to mice with persistent warts\n(n = 3). The changes in skin wart burden is documented at\ntwo weeks post adoptive T cell transfer. In control group (n =\n3), T cells represent naïve T cells as found in the spleen of uninfected\nwild-type FVB mice. f-i, Skin tumor development in DMBA-TPA-treated\nMmuPV1-colonized wild-type FVB mice (MmuPV1/DMBA-TPA, n = 10)\ncompared with DMBA-TPA-treated sham-infected (Sham/DMBA-TPA, n\n= 10) and MmuPV1-colonized mice (MmuPV1/-, n = 10).\n(f) Time to tumor onset (Log-rank test), (g)\nnumber of skin tumors over time, (h) tumor burden at the completion\nof the study, and (i) representative images of mice in\nDMBA-TPA-treated cohorts (*p < 0.05, two-tailed\nMann-Whitney U test). j, Mice that rejected their\nskin warts after receiving T cells from MmuPV1-colonized immune mice (test T\ncells in “e”, n = 3) compared with\nwart-bearing nonimmune mice (n = 3) following DMBA-TPA\ntreatment. Note that the nonimmune mice developed invasive skin cancers at 8\n(mouse #4), 15 (mouse #5) and 20 (mouse #6) weeks post DMBA treatment (red\ncircles). Mice were shaved to enable better visualization of the skin tumors.\nData represent two independent sets of experiments with similar results. Scale\nbars: 1 cm, error bars represent the mean ± SD.",
  "figure_2": "a-c, SKH-1 mice with MmuPV1-colonized back skin and no\nwarts (i.e., immune) were subjected to DMBA-UV carcinogenesis protocol.\n(a) Time to tumor onset (ns: not significant, Log-rank test),\n(b) tumor counts per mouse over time, and (c) the\nnumber of tumors for each mouse at the completion of the carcinogenesis protocol\ncompared between the following groups: DMBA-UV-treated MmuPV1-colonized SKH-1\nmice (MmuPV1/DMBA-UV, n = 10), DMBA-UV-treated sham-infected\nmice (Sham/DMBA-UV, n = 10) and MmuPV1-colonized mice\n(MmuPV1/-, n = 5). *p < 0.05,\ntwo-tailed Mann-Whitney U test. d, Representative\nimages of mice in DMBA-UV treatment groups (scale bar: 1 cm). Note the\nresemblance of DMBA-UV-induced skin tumors to actinic keratosis and SCC in\nhumans. e, Representative images of CD8+ T cells in the\nskin of MmuPV1/DMBA-UV and Sham/DMBA-UV mice at the completion of the\ncarcinogenesis protocol. Arrows point to epidermal CD8+ T cells,\ndashed lines highlight the epidermal basement membrane, scale bar: 100\nμm. f, CD8+ T cell infiltrates in MmuPV1/DMBA-UV\n(n = 10) and Sham/DMBA-UV (n = 9) skin\nquantified in ten randomly selected high power field (hpf) images per mouse and\naveraged across the mice in each group (two-tailed unpaired\nt-test). g, The ratio of epidermal CD8+\nT cells (i.e., CD8+ TRM cells) over the total T cell count\nin each high power image calculated across MmuPV1/DMBA-UV (n =\n10) and Sham/DMBA-UV (n = 9) groups (two-tailed unpaired\nt-test). Data represent two independent sets of experiments\nwith similar results. Each dot represents one high power image, stained cells\nwere counted blindly, error bars represent the mean ± SD.",
  "figure_3": "a, Representative β-HPV RNAish-stained (red dots)\nsections of SCC from immunosuppressed and immunocompetent patients. Wart sample\nserves as a positive control and exhibits the greatest amount of β-HPV\nactivity. Hypertrophic actinic keratosis arising in association with a wart (HAK\nin verruca) is another example of a β-HPV-active lesion found on the skin\nof immunosuppressed patients. Insets highlight the representative areas of the\ncancer/wart and their adjacent normal skin (scale bars: 100 μm).\nb, β-HPV RNAish signals quantified in paired samples of\nskin cancer and its adjacent normal skin collected from immunosuppressed\n(n = 38) and immunocompetent patients (n =\n32). Skin cancer characteristics are listed in Supplementary Table 2 (two-tailed\npaired t-test). c, d, Representative\n(c) flow plots and (d) quantification of\nCD69+ and CD137+ CD69+ CD8+ T\ncells isolated from human facial skin and used in a β-HPV peptide\nstimulation assay (n = 6 biological replicates in each\ntreatment condition). T cells were isolated from eight facial skin samples (6\nmales and 2 females, average age: 75, age range: 60–89). Percentage of\nCD8+ T cells in each quadrant is listed on the flow plots.\nPMA/Ionomycin stimulation was used as a positive control. Details of peptide\npool can be found in methods section and Supplementary Table 3. Error bars\nrepresent the mean + SD, RNAish signals were counted blindly,\n*p < 0.05, **p < 0.01, ns:\nnot significant compared with negative control, two-tailed Mann-Whitney\nU test.",
  "figure_4": "a, Wart burden in\nCD4−/−;CD8−/− mice\n(right) compared with the absence of warts in wild-type mice (left)\nfollowing MmuPV1 infection of the back skin at ten weeks post-infection.\nNote the confluent pattern of wart development in the T cell deficient\nmouse. b, MmuPV1-induced wart in\nCD4−/−;CD8−/− mouse\nstained with hematoxylin and eosin (H&E) (left), MmuPV1 L2 RNAish\n(middle) and negative control RNAish probe (right; scale bar: 1 mm).\nc, Representative images of wild-type C57BL/6J mice back\nskin on the day of MmuPV1 infection and 21 days post-infection. MmuPV1 L1\nPCR on 20 segments of the back skin. A typical wild-type C57BL/6J mouse five\nweeks post-infection, highlighting the absence of warts in 100% of the\nanimals. d, Macroscopic images of wild-type C57BL/6J mice\ninfected with MmuPV1 on their back skin or sham infected and treated with\nDMBA-TPA. Representative images of the mice are shown. Papillomas and\ninvasive skin cancer are highlighted with yellow and red circles,\nrespectively. e, Representative images of the back skin of\nwild-type FVB mice on the day of MmuPV1 infection and 31 days\npost-infection. Mice were shaved for visualization of the skin and skin\ntumors, scale bars: 1 cm, MmuPV1 L1 PCR bands are marked by arrows, PCR\namplicon size: 339 bp, PCR primers, forward: GAGCTCTTTGTTACTGTTGTC, reverse:\nATCCTCTCTTTCCTTGGGC, M: molecular-weight size marker, P1–3: positive\ncontrols, N: negative control.",
  "figure_5": "a, Schematic of T cell transfer experiment. Flow sort\ngating strategy is provided in the inset showing the selection of memory T\ncells. T cell donor mice received CD45-APC (BioLegend) intravenously three\nminutes prior to harvest to label and exclude the circulating immune cells.\nNote that parvovirus vaccination control experiment was done in parallel\nwith the MmuPV1 challenged mice. b, Representative images of\nthe warts on the back skin of mice three weeks after MmuPV1 infection. Flow\ncytometry demonstrates the presence of CD4+ and CD8+ T\ncells in the peripheral blood of the recipient mice, indicating a successful\nadoptive T cell transfer (n = 4 per group, scale bar: 1cm).\nc, Growth of subcutaneously injected DMBA-TPA-induced\nprimary SCC tumor cells in wild-type (Wt, n = 9),\nCD4−/−;CD8−/−\n(n = 5), and\nCD4−/−;CD8−/− mice\nthat received T cells from MmuPV1-immune donors (test T cells,\nn = 4). Note that SCC primary tumor growth experiment\nwas done in parallel with the MmuPV1 challenged mice. Error bars represent\nthe mean + SD, *p < 0.05 compared with Wt group,\ntwo-tailed Mann-Whitney U test.",
  "figure_6": "a, b, MmuPV1 L1 PCR on DNA isolated from the skin of\nwild-type (a) C57BL/6J (B6) and (b) FVB mice\n>6 months after the infection. MmuPV1 L1 PCR bands are highlighted by\narrows, PCR amplicon size: 339 bp, M: molecular-weight size marker, +:\npositive control, -: negative control. c, d, Anti-MmuPV1\nseroconversion in DMBA-TPA-treated cohorts of (c) C57BL/6J\n(n = 5 per group) and (d) FVB mice\n(n = 4 per group). *p < 0.05,\n**p < 0.01, ns: not significant, two-tailed\nMann-Whitney U test. e, Representative images\nof CD3 and CD45-stained skin from MmuPV1-colonized FVB mice compared with\ntheir sham-infected controls at the completion of the chemical\ncarcinogenesis protocol. Arrows point to T cells in the epidermis, dashed\nlines highlight the epidermal basement membrane. f,\nCD45+ leukocytes quantified in skin sections of\nMmuPV1/DMBA-TPA and Sham/DMBA-TPA FVB mice across ten random high power\nfield (hpf) images of normal skin from each mouse and averaged across the\nmice in each group (two-tailed unpaired t-test). Each dot\nrepresents leukocyte count in one high power image, n = 8\nfor the number of mice in each group. g, h, Epidermal T cell\nhoming in DMBA-TPA-treated MmuPV1-colonized skin compared with\nDMBA-TPA-treated sham-infected skin of wild-type FVB mice. (g)\nRepresentative images CD8/CD3- and CD4/CD3-stained skin sections. Arrows\npoint to the epidermal CD8+ TRM cells, dashed lines\nhighlight the epidermal basement membrane. (h) The ratios of\nepidermal CD8+ TRM and CD4+ TRM\ncells to total CD3+ T cells in the skin per hpf image (two-tailed\nunpaired t-test). T cells in up to ten random hpf images of\nthe normal skin from each mouse were counted. Each dot represents one high\npower image. n = 10 for MmuPV1/DMBA-TPA and 9 for\nSham/DMBA-TPA group. i, Representative skin tumors from\nMmuPV1/DMBA-TPA and Sham/DMBA-TPA wild-type FVB mice stained with keratin 6\n(K6, a marker for epidermal hyperplasia) and Ki67 (a proliferation marker).\nDashed lines highlight the epidermal basement membrane in the skin.\nj, PCR amplification of the wild-type (A) and mutant (T)\nregion of Hras gene in DNA of MmuPV1/DMBA-TPA and\nSham/DMBA-TPA tumors, skin, and an untreated skin from a wild-type FVB mouse\n(band size: 110 bp). Note that Hras codon 61 A to T\nmutation highlights DMBA-TPA induced skin tumors in MmuPV1/DMBA-TPA and\nSham/DMBA-TPA wild-type FVB cohorts. k, Matched H&E and\nMmuPV1 RNAish images of a wart from an MumPV1-infected\nCD4−/−;CD8−/− mouse, a\nskin tumor and normal skin from MmuPV1-colonized DMBA-TPA-treated wild-type\nmouse. Note the dense and confluent RNAish signals in the wart from T cell\ndeficient mouse. After the completion of DMBA-TPA treatment, positive MmuPV1\nRNAish signals are detectable in the normal skin of a wild-type mouse. The\nskin tumor from the same mouse lacks MmuPV1 RNAish signal. Stained cells\nwere counted blindly, error bars represent the mean ± SD, scale bars:\n100 μm.",
  "figure_7": "a, Representative images of SKH-1 mice with no evidence\nof disease following infection (immune) and mice with visible warts after\nback skin infection with MmuPV1 (nonimmune). MmuPV1 L2 RNAish of an immune\nmouse and a nonimmune mouse skin harvested three weeks after MmuPV1\ninfection to detect viral activity in the normal skin and the MmuPV1-driven\nwart. Insets highlight the active virus in the normal skin of the immune\nmouse and the wart of the nonimmune mouse. b, Macroscopic\nimages of the SKH-1 mice three months after MmuPV1 back skin infection.\nSKH-1 mice with spontaneous immunity to the virus (no wart) treated one time\nwith an immunosuppressive dose of UVB (300 mJ/cm2). Images of the\nmice three weeks after UV treatment are shown. Arrows point to the newly\ndeveloped warts on the UV-treated skin. c, The histological\nimages of H&E and MmuPV1 RNAish stained wart (yellow circle). Inset is\nmagnified to highlight MmuPV1-induced cytopathic changes in the H&E\nimage and confluent positive MmuPV1 RNAish signals in the wart.\nd, Macroscopic images of MmuPV1-infected SKH-1 mice that\ncontinued to have warts (yellow arrows) before MmuPV1 vaccination, four\nweeks after vaccination and at the completion of the UV carcinogenesis\nprotocol. The nine wart-bearing mice were treated with MmuPV1 virus\nparticles intraperitoneally three times over two weeks. Four weeks later,\nthe mice underwent UV carcinogenesis protocol. Mice with acquired antiviral\nimmunity (n = 5) are compared with nonimmune mice that have\npersistent warts (n = 4). e, Skin tumor burden\nin vaccinated immune (n = 5) and nonimmune mice\n(n = 4) treated with UV carcinogenesis protocol. In\nmice with confluent pattern of skin tumors, counts represent the individual\nlesions prior to their coalescence, error bars represent the mean ±\nSD, two-tailed Mann-Whitney U test. f,\nRepresentative images of CD3/CD45-stained skin from MmuPV1-colonized SKH-1\nmice compared with their sham-infected controls at the completion of the UV\ncarcinogenesis protocol. Arrows point to T cells in the epidermis.\ng-i, Skin infiltrating (g) total\nCD45+ leukocytes, (h) CD3+\nCD45+ T cells and (i) CD3-\nCD45+ leukocytes quantified in CD3/CD45-stained skin sections\nof MmuPV1/DMBA-UV (n = 10) and Sham/DMBA-UV\n(n = 9) SKH-1 mice across ten random hpf images of each\nskin sample and averaged across the mice in each group. Each dot represents\none high power image. Note the trend toward T cell increase and\nCD3- inflammatory cell decrease in MmuPV1/DMBA-UV skin\ncompared with Sham/DMBA-UV control. Error bars represent the mean + SD,\ntwo-tailed unpaired t-test. j, Representative\nimages of CD3/CD45-stained cells in the skin tumors of MmuPV1-colonized\nSKH-1 mice compared with their sham-infected controls at the completion of\nthe UV carcinogenesis protocol. Insets are magnified to highlight the immune\ncells in the tumor parenchyma. k-m, Tumor infiltrating\n(k) total CD45+ leukocytes, (l)\nCD3+ CD45+ T cells and (m)\nCD3- CD45+ leukocytes quantified in\nCD3/CD45-stained sections of MmuPV1/DMBA-UV and Sham/DMBA-UV SKH-1 skin\ntumors across hpf images of each tumor and averaged across the mice in each\ngroup. 12 early skin tumors are included in each group, each dot represents\none high power image. Error bars represent the mean + SD, two-tailed\nunpaired t-test, stained cells were counted blindly, dashed\nlines highlight the epidermal basement membrane. Scale bars, mouse: 1 cm,\ntissue: 100 μm.",
  "figure_8": "a, Representative images of CD8+ T cells in\nthe skin tumors of MmuPV1-colonized SKH-1 mice compared with their\nsham-infected controls at the completion of the UV carcinogenesis protocol.\nInsets are magnified to highlight T cells in the tumor parenchyma.\nb-d, Tumor infiltrating (b) CD3+,\n(c) CD8+ and (d) CD4+ T\ncells quantified in CD8/CD3- and CD4/CD3-stained tumor sections of\nMmuPV1/DMBA-UV and Sham/DMBA-UV SKH-1 mice across hpf images of each tumor\nand averaged across the mice in each group. 12 early skin tumors are\nincluded in each group, each dot represents one high power image. e,\nf, CD4+ T cell infiltrates in the MmuPV1-colonized and\nsham-infected SKH-1 skin shown by (e) representative images of\nthe CD4/CD3-stained skin sections (arrows point to the epidermal\nCD4+ TRM cells) and (f)\nquantification of CD4+ T cells per high power image of the skin.\nTen random hpf images of the skin from each mouse in each group are\nincluded. Each dot represents one high power image. n = 10\nin MmuPV1/DMBA-UV and n = 9 in Sham/DMBA-UV group.\ng, Schematic diagram of anti-CD8/IgG antibody treatment\ncombined with UV carcinogenesis protocol. Four weeks post-MmuPV1 or\nsham(VLP) infection, mice were started on anti-CD8 or IgG isotype control\nantibody treatment (red arrows). A day after first antibody treatment, the\nback skin of SKH-1 mice was treated with 50 μg of DMBA once (green\ntriangle). Seven days later, mice were started on UVB (100\nmJ/cm2) three times a week (yellow triangles). h,\nFlow analysis on spleen and skin of MmuPV1/DMBA-UV mice treated with\nanti-CD8 or IgG antibody to evaluate CD8+ T cell depletion\nefficiency at six weeks post-DMBA. Percentage of CD8+ T cells are\nlisted on each plot. i, Skin tumor burden in MmuPV1-colonized\nmice treated with IgG control (MmuPV1+IgG, n = 10),\nanti-CD8 antibody (MmuPV1+anti-CD8, n = 10),\nsham(VLP)-infected mice treated with IgG control (Sham(VLP)+IgG,\nn = 7) and anti-CD8 antibody (Sham(VLP)+anti-CD8,\nn = 7) after DMBA-UV treatment (error bars represent\nthe mean ± SD, *p < 0.05, ns: not\nsignificant, two-tailed Mann-Whitney U test).\nj, Representative images of mice in the four treatment\ngroups. Due to the large skin tumors in MmuPV1-colonized CD8+ T\ncell-depleted mice, the UV carcinogenesis study was terminated at 18 weeks\npost-DMBA. k, l, XPCKO mice infected with MmuPV1 on their back\nskin (n = 15) or sham infected (n = 13),\nsubjected to the UV carcinogenesis protocol and their skin tumor outcomes\ndocumented as latency to (k) first skin tumor development and\n(l) first invasive skin cancer development (Log-rank test).\nNote that all XPCKO mice in the study were immune to MmuPV1 (i.e., no wart\ndevelopment). m, Representative images of XPCKO mice at the\ncompletion of 30-week UV carcinogenesis protocol. Premalignant tumors\n(papillomas) and invasive skin cancers are highlighted with yellow and red\ncircles, respectively. Mice were shaved for UV treatments and the\nvisualization of the skin tumors. n, Representative\nH&E-stained histological images of a papilloma in MmuPV1/DMBA-UV and\ninvasive skin cancer in Sham/DMBA-UV XPCKO mice. Inset shows the cellular\natypia in the Sham/DMBA-UV skin cancer (scale bar: 50 μm). ns: not\nsignificant, two-tailed unpaired t-test, error bars\nrepresent the mean + SD, stained cells were counted blindly, dashed lines\nhighlight the epidermal basement membrane, scale bars, mouse: 1 cm, tissue:\n100 μm.",
  "figure_9": "a, β-HPV RNAish and DNAish probes binding site\nshown on HPV9 genome. The RNAish and DNAish probe against each β-HPV\ntype was constituted of a pool of 20 double Z probes targeting a region of\n1,000 bases (Advanced Cell Diagnostics, California, USA). b,\nH&E and RNAish staining of a wart from a 63-year-old immunosuppressed\nfemale. Note the abundance of positive signals (red dots) throughout the\nwart. c, β-HPV RNAish of a skin cancer from an\n87-year-old immunosuppressed female including the positive and negative\ncontrol probe stains. The detection of β-HPV by RNAish correlates\nwith qRT-PCR positivity for HPV5 and 9 E6 protein transcripts in the same\nskin cancer. A sample of normal skin from an 18-year-old immunocompetent\nAfrican American female stained with β-HPV RNAish probes. The lack of\nRNAish signal (red) in this sample correlates with undetectable HPV5, 9 or\n15 E6 protein transcripts on qRT-PCR of the same sample. qRT-PCR products\nvisualized using gel electrophoresis. PCR band size: HPV5 E6: 100 bp, HPV9\nE6: 66 bp, HPV15 E6: 78 bp, Keratin 14: 109 bp, M: molecular-weight size\nmarker, scale bars: 100 μm.",
  "figure_10": "a, β-HPV RNAish signal counts in the skin cancer\ncells compared between immunosuppressed (n = 38) and\nimmunocompetent (n = 32) patients. b, A\nclinical image of a skin cancer surgical site showing the skin cancer (red\narrow), its adjacent normal skin (green arrow) and the normal skin away from\ncancer site (blue arrow). c, Quantification of β-HPV\nRNAish signals in high power images across the immunosuppressed lesions,\nimmunocompetent lesions and normal facial skin away from a cancer site. Skin\nlesions include β-HPV RNAish signal counts from skin cancer (red\ndots) and the adjacent normal skin (green dots) images. 30 normal facial\nskin samples (blue dots) from immunocompetent patients are included (18\nmales and 12 females, average age: 71, range: 39–94). d,\nRepresentative low and high magnification images of β-HPV\nRNAish-stained normal skin samples from immunosuppressed and immunocompetent\npatients. Note the density and size of the apparent RNAish signals in basal\nlayer keratinocytes of an immunosuppressed patient. e, The\ndensity of β-HPV RNAish signals in basal layer keratinocytes\nquantified across 38 immunosuppressed and 31 immunocompetent skin samples.\nf, β-HPV DNA in situ hybridization (DNAish) to\ndetect β-HPV viral load in the skin. Compared to β-HPV RNAish\nthat marks viral transcripts, β-HPV DNAish is a novel tool to detect\nviral load at a subcellular resolution in skin keratinocytes. Note the\nhigher level of viral DNA signals compared with RNA, and the localization of\nthe signals in the keratinocytes’ nucleus and cytoplasm. Error bars\nrepresent the mean + SD, ns: not significant, two-tailed unpaired\nt-test, scale bars: 50 μm.",
  "figure_11": "a, Representative images of CD3/CD103-stained squamous\ncell carcinoma from immunosuppressed and immunocompetent patients (same\ncancers are shown for β-HPV RNAish and DNAish stains in Fig. 3a and Extended Data Fig. 8a). Insets are magnified to\nhighlight CD103+ TRM cells in the cancer and adjacent\nnormal skin, scale bars: 100 μm. b, c,\nCD3/CD8/CD103-stained skin cancer sections used to quantify (b)\nCD3+ T, CD103+ CD3+ TRM,\nCD8+ T and CD103+ CD8+ TRM\ncells infiltrating the skin cancer parenchyma (tumor infiltrating), and\n(c) CD3+ T, CD103+ CD3+\nTRM, CD8+ T and CD103+ CD8+\nTRM cells in the adjacent normal skin of immunosuppressed (S)\nversus immunocompetent (C) patients. Note that most T cells in the normal\nskin reside in the dermis. Stained cells were counted blindly in ten random\nhpf images of skin cancer and adjacent normal skin from each tissue specimen\nand averaged across the samples in each group, 37 immunosuppressed and 32\nimmunocompetent skin cancer samples are included (skin cancer\ncharacteristics are listed in Supplementary Table 2), each\ndot represents the average of the T cell counts in the high power images\nfrom each sample, error bars represent the mean + SD, two-tailed unpaired\nt-test. d, Cytotoxic T lymphocyte\ndegranulation following exposure to β-HPV peptides. T cells isolated\nfrom normal facial skin of adults were exposed to β-HPV E7 peptides\n(far left), HPV16 E7 peptides (middle left), PMA/ionomycin (positive\ncontrol) and media (negative control). Representative flow plots are shown.\nPercentage of CD107a+ CD8+ T cells are listed on each\nplot. Data represent two independent sets of experiments with similar\nresults.",
  "figure_12": "a, Principle Component Analysis (PCA) of gene\nexpression profiles obtained from MmuPV1-induced warts (n =\n4, blue triangles), MmuPV1 (n = 4, pink squares) or sham\n(n = 4, grey circles) infected skin, and MmuPV1\n(n = 4, red squares) or sham (n = 4,\nblack circles) infected tumors of SKH-1 mice. Note that DMBA-UV-induced skin\ntumors from MmuPV1-infected mice are indistinguishable from skin tumors from\nSham-infected mice, while both have a very distinct transcriptional profiles\ncompared with MmuPV1-driven warts. b, c, Volcano plots of\ndifferentially expressed genes in (b) MmuPV1- versus\nsham-infected skin (n = 4 per group) and (c)\nskin tumors and warts (n = 12) compared with MmuPV1- and\nsham-infected skin (n = 8). Differential expression\nanalysis was performed by Novogene Co. (Sacramento, CA) using the DESeq2 R\npackage. P values were calculated using DESeq2 R package (V2_1.6.3). The\nresulting P values were adjusted using the Benjamini and Hochberg’s\napproach for controlling the False Discovery Rate (FDR). The 20 genes that\nwere up-regulated in skin tumors and warts compared with MmuPV1- and\nsham-infected skin are shown in a table. d-f, The immune gene\nexpression analysis on human skin lesions based on the mouse RNAseq data.\nd, Representative macroscopic and H&E-stained\nhistological images of SCC, wart, seborrheic keratosis (SK) and normal human\nskin (scale bar: 500 μm). e, The relative gene\nexpression in SCCs (n = 7) and warts (n =\n5) compared with normal skin (n = 8). f, The\nnormalized relative gene expression in SCCs (n = 7), warts\n(n = 5) and SKs (n = 5) compared for\nseveral DAMP genes. Average relative gene expression in the normal skin was\nused for normalization. GAPDH is used as the refence gene,\n*p < 0.05, **p < 0.01,\ntwo-tailed Mann-Whitney U test, error bars represent the\nmean + SD."
}